Teligent, a manufacturer of generic pharmaceutical products for the U.S. and Canadian market, was facing bankruptcy, and the custodian engaged PharmaBioSource Realty, LLC as the exclusive real estate broker to market and sell the company’s manufacturing facility in Buena, NJ. The 110,000 SF facility housed topical liquids / creams manufacturing and packaging suites as well as a brand new sterile drug product suite. The custodian faced an expedited sale / auction process, and speed to close a transaction was imperative.

PharmaBioSource Realty engaged the pharmaceutical and biotech industry to market and sell the Buena facility to a strategic acquirer. We drew on our real estate and technical expertise, along with our extensive contacts within the pharmaceutical industry, to identify qualified potential buyers for the site.

Services provided by the PharmaBioSource Realty team:

• Site, facility, and equipment assessments
• Benchmark valuation
• Prep for sale
• Creation of introductory project teaser
• Target identification and marketing
• Support in developing a data room
• Managed confidentiality agreements
• Hosted site visits and meetings with Teligent and buyer management
• Supported buyer due diligence
• Contract documents
• Deal structure and negotiations
• Closing

PharmaBioSource Realty identified Leiters, a Colorado-based 503B sterile hospital and ophthalmic manufacturer, as the successful buyer. The $27M transaction closed in just four months from initial engagement.